Suven Life Sciences Limited (NSE:SUVEN)
188.73
+3.76 (2.03%)
May 16, 2025, 3:30 PM IST
Suven Life Sciences Statistics
Total Valuation
NSE:SUVEN has a market cap or net worth of INR 41.18 billion. The enterprise value is 40.58 billion.
Market Cap | 41.18B |
Enterprise Value | 40.58B |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 218.07M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.22% |
Shares Change (QoQ) | -0.45% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 543.74 |
PB Ratio | 21.37 |
P/TBV Ratio | 21.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -28.31 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,065.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -37.09% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 537,163 |
Profits Per Employee | -10.17M |
Employee Count | 141 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.78% in the last 52 weeks. The beta is 0.64, so NSE:SUVEN's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | +87.78% |
50-Day Moving Average | 129.47 |
200-Day Moving Average | 132.88 |
Relative Strength Index (RSI) | 80.67 |
Average Volume (20 Days) | 1,575,331 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUVEN had revenue of INR 75.74 million and -1.43 billion in losses. Loss per share was -6.58.
Revenue | 75.74M |
Gross Profit | 67.50M |
Operating Income | -1.58B |
Pretax Income | -1.44B |
Net Income | -1.43B |
EBITDA | -1.52B |
EBIT | -1.58B |
Loss Per Share | -6.58 |
Balance Sheet
The company has 1.66 billion in cash and 2.44 million in debt, giving a net cash position of 1.66 billion.
Cash & Cash Equivalents | 1.66B |
Total Debt | 2.44M |
Net Cash | 1.66B |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.93B |
Book Value Per Share | 8.81 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 89.12% |
Operating Margin | -2,086.21% |
Pretax Margin | -1,905.77% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NSE:SUVEN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.22% |
Shareholder Yield | -0.22% |
Earnings Yield | -3.48% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |